James D. Chalmers

Active 1981–2026

Also published as
James D Chalmers
288
Papers
32,320
Citations
95
h-index
270
i10-index

Citations

Citations per year for James D. Chalmers1916: 3 citations1988: 1 citations1991: 1 citations1993: 2 citations1995: 1 citations1996: 3 citations1997: 3 citations1998: 1 citations1999: 1 citations2000: 1 citations2003: 2 citations2005: 1 citations2006: 2 citations2007: 2 citations2008: 2 citations2009: 17 citations2010: 17 citations2011: 30 citations2012: 42 citations2013: 57 citations2014: 59 citations2015: 70 citations2016: 138 citations2017: 126 citations2018: 269 citations2019: 745 citations2020: 933 citations2021: 1,188 citations2022: 1,229 citations2023: 1,200 citations2024: 2,467 citations2025: 1,259 citations2026: 26 citations1917–1987: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992: no citations, so this year is not shown1994: no citations, so this year is not shown2001–2002: no citations, so these years are not shown2004: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,565 citing papers, 16.4% of this breakdownUnited Kingdom: 1,130 citing papers, 11.9% of this breakdownChina: 856 citing papers, 9% of this breakdownSpain: 526 citing papers, 5.5% of this breakdownItaly: 498 citing papers, 5.2% of this breakdownAustralia: 430 citing papers, 4.5% of this breakdownGermany: 414 citing papers, 4.4% of this breakdownCanada: 327 citing papers, 3.4% of this breakdownFrance: 311 citing papers, 3.3% of this breakdownNetherlands: 256 citing papers, 2.7% of this breakdownBelgium: 183 citing papers, 1.9% of this breakdownSwitzerland: 165 citing papers, 1.7% of this breakdown
0%16.4%Other 30.1%

Fields

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology11.2%
  • Immunology and Microbiology6%
  • Health Professions1.4%
  • Environmental Science1.2%
  • Engineering1.1%
  • Other4.9%

Topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research5.8%
  • Cystic Fibrosis Research Advances5.7%
  • Pneumonia and Respiratory Infections4.4%
  • Long-Term Effects of COVID-194.2%
  • Neonatal Respiratory Health Research2.9%
  • COVID-19 Clinical Research Studies2.8%
  • Other74.2%

Coauthors

All papers

Open in search
  1. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 650

  2. Pneumonia

    Authors: , , , , , , - Nature Reviews Disease Primers 2021 cited by 806

  3. European Respiratory Society guidelines for the management of adult bronchiectasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,344

  4. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Davies, Anthony De Soyza, J R Geddes, William Greenhalf, Neil Greening, Liam G. Heaney, Simon Heller, Luke Howard, Joseph Jacob, Gísli Jenkins, Janet M. Lord, William D‐C Man, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Malcolm G. Semple, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Ryan S. Thwaites, Andrew Briggs, Annemarie B Docherty, S Kerr, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Mathew Thorpe, Bang Zheng, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, K Poinasamy, Betty Raman, Ewen M. Harrison, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, R Adrego, L A Aguilar Jimenez, Shazaad Ahmad, Nafees Haider, Rizwan Ahmed, N Ahwireng, Mark Ainsworth, B Al-Sheklly, A Alamoudi, Mohammad Ali, M Aljaroof, AM All, Louise Allan, R Allen, L. Allerton, Lynne Allsop, P. Almeida, Doris Altmann, Maria Alvarez Corral, S Amoils, Debra Anderson, Chrystalina A. Antoniades, G Arbane, A. Arias, Chérie Armour and 906 more - The Lancet Respiratory Medicine 2022 cited by 424

  5. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2023 cited by 280

  6. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janet M. Lord, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Dhruv Parekh, Paul Pfeffer, Najib M. Rahman, Betty Raman, Matthew Richardson, Matthew Rowland, Malcolm G. Semple, Ajay M. Shah, Sally Singh, Aziz Sheikh, David Thomas, Mark Toshner, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, Famous O. Adeyemi, Shazaad Ahmad, Rizwan Ahmed, Mark Ainsworth, B Al-Sheklly, Asma Khalid Alamoudi, M Aljaroof, Louise Allan, R Allen, A Alli, Doris Altmann, Debra Anderson, Michele Andrews, Adrienn Angyal, Chrystalina A. Antoniades, G Arbane, Chérie Armour, Natalie Armstrong, Lará Armstrong, H Arnold, David Arnold, Mark Ashworth, Andrew Ashworth, H Assefa-Kebede, Philip A. Atkin, H. Atkins, Amy Atkins, Raminder Aul, Cristina Avram, Rob Baggott, David Baguley, J. Kenneth Baillie, S. Bain, M Bakali, M Bakau, Eileen Baldry, David Baldwin, Clive Ballard, J. Bambrough, Ruth E Barker, Shaney Barratt, Fiona Barrett, D Basire and 680 more - The Lancet Respiratory Medicine 2021 cited by 659

  7. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity

    Authors: , , - The Lancet 2018 cited by 535

  8. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 353

  9. The Bronchiectasis Severity Index. An International Derivation and Validation Study

    Authors: , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2014 cited by 1,095

  10. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Welte, Robert C. Wilson, Conroy Wong, James D. Chalmers - The Lancet Respiratory Medicine 2021 cited by 285

  11. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 238

  12. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2023 cited by 285

  13. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore J. Iwashyna, Gísli Jenkins, Martin Kolb, Guy B. Marks, Peter J. Mazzone, J. Randall Moorman, Thomas M. Murphy, Terry L. Noah, Paul N. Reynolds, Dieter Riemann, Richard Russell, Aziz Sheikh, Giovanni Sotgiu, Erik R. Swenson, Rhonda D. Szczesniak, Ronald Szymusiak, Jean–Louis Teboul, Jean‐Louis Vincent - Annals of the American Thoracic Society 2018 cited by 722

  14. Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 230

  15. Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy

    Authors: , - European Respiratory Review 2022 cited by 164

  16. Integrative microbiomics in bronchiectasis exacerbations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 233

  17. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis

    Authors: , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2017 cited by 414

  18. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease

    Authors: , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 242

  19. openalex_id:w4223924695

    Authors: , , , , , , , , , , , , , , , , , , cited by 147

  20. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 448

  21. Bronchiectasis

    Authors: , , , , - Nature Reviews Disease Primers 2018 cited by 347

  22. Characterization of the “Frequent Exacerbator Phenotype” in Bronchiectasis

    Authors: , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 338

  23. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

    Authors: , , , , , , , , - The Lancet Respiratory Medicine 2019 cited by 205

  24. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul J. Harrison, PHOSP-COVID Study Collaborative Group - Nature Medicine 2023 cited by 97